01—Abstract
Summary
Summary of the 10-Q filed November 2, 2022. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. reported solid revenue growth for the nine months ended September 30, 2022, with total revenues increasing by 8% to $3.81 billiona, driven primarily by a 12% rise in clearing and transaction fees.
This growth was supported by a significant 23% increase in total contract volume, reflecting heightened market volatility in interest rate and equity index products due to inflation concerns and Federal Reserve policy shifts. While revenue grew, total expenses saw a decrease of 4% year-over-year, leading to an improved operating margin of 61.6% for the nine-month period. Despite a substantial decrease in non-operating income, primarily due to a lower net gain from the OSTTRA joint venture in the prior year and increased expenses related to interest distribution on performance bond collateral, net income attributable to CME Group remained relatively stable at $2.05 billionb for the nine months ended September 30, 2022, a slight increase of 2% compared to the prior year.
Diluted earnings per share also saw a modest increase. The company's financial position remains strong, with significant liquidity and robust capital resources, including a substantial amount of cash and cash equivalents and undrawn credit facilities.
02—Key points
Key Highlights
- Total revenues increased by 8% to $3.81 billion for the first nine months of 2022, driven by a 12% increase in clearing and transaction fees.
- Total contract volume rose by 23% for the first nine months of 2022, with notable growth in interest rate (24%) and equity index (44%) products, reflecting increased market volatility.
- Total expenses decreased by 4% for the first nine months of 2022 due to lower compensation and benefits, professional fees, and other operating costs.
- Net income attributable to CME Group increased by 2% to $2.05 billion for the first nine months of 2022.
- Diluted earnings per share increased slightly to $5.64 for the first nine months of 2022.
- Cash flow from operating activities increased by 20% to $2.07 billion for the first nine months of 2022.
- The company maintained strong liquidity with $2.1 billion in cash and cash equivalents and significant access to revolving credit facilities totaling $9.3 billion.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2022filed November 2, 2022Financial Statements
Q3 FY2022 against Q3 FY2021
| Line item | Q3 FY2022Q3 FY2021 | Change |
|---|---|---|
| Revenue | $1.23B$1.11B | +10.6% |
| Operating Expenses | $489.00M$496.20M | −1.5% |
| Operating Income | $738.80M$613.70M | +20.4% |
| Net Income | $679.60M$926.50M | −26.6% |
| EPS (Basic) | $1.87$2.59 | −27.8% |
| EPS (Diluted) | $1.87$2.58 | −27.5% |
| Shares Outstanding (Basic) | 358.71M358.36M | +0.1% |
| Shares Outstanding (Diluted) | 359.29M358.99M | +0.1% |
05—Questions
Frequently Asked Questions
What drove the increase in revenue for CME Group in the first nine months of 2022?
Revenue increased by 8% to $3.81 billion, primarily driven by a 12% rise in clearing and transaction fees. This was supported by a substantial 23% increase in total contract volume, particularly in interest rate and equity index products, which saw increased trading activity due to market volatility stemming from inflation concerns and changing interest rate policies.
How did expenses change during the period, and what was the impact on profitability?
Total expenses decreased by 4% to $1.46 billion for the first nine months of 2022. This reduction was mainly due to lower compensation and benefits, professional fees, and other operating costs. The decrease in expenses, coupled with revenue growth, contributed to an improved operating margin and a modest 2% increase in net income attributable to CME Group, which reached $2.05 billion.
What is the company's liquidity position and outlook?
CME Group maintained a strong liquidity position with $2.1 billion in cash and cash equivalents as of September 30, 2022. Additionally, the company has access to significant credit facilities totaling $9.3 billion ($2.3 billion senior revolving credit facility and a $7.0 billion clearing house facility), of which none were drawn as of the reporting date. This robust liquidity and strong cash flow generation support the company's operations and financial flexibility.
What factors contributed to the volatility in non-operating income?
Non-operating income decreased significantly by 44% for the nine months ended September 30, 2022. This was mainly due to a lower net gain recognized from the OSTTRA joint venture in the prior year and higher expenses related to the distribution of interest earned on performance bond collateral reinvestments, driven by increased interest income from higher rates.
06—Continue